Insider · CIK 0001615856

Gottesdiener Keith Michael

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001615856

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.3K sh	—	—	11,260
2025-09-25	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33.2K sh	—	—	33,246
2025-05-08	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+100K sh	—	—	300,000
2025-02-28	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+500K sh	—	—	500,000
2024-12-05	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+100K sh	—	—	200,000
2024-10-08	PRMEPrime Medicine, Inc.G Gift	Director, See Remarks	GGift	−227K sh	—	—	50,241
2024-10-08	PRMEPrime Medicine, Inc.G Gift	Director, See Remarks	GGift	+227K sh	—	—	682,259
2024-06-05	PRMEPrime Medicine, Inc.G Gift	Director, See Remarks	GGift	+250K sh	—	—	277,166
2024-06-05	PRMEPrime Medicine, Inc.G Gift	Director, See Remarks	GGift	−250K sh	—	—	2,310,837
2024-02-25	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+100K sh	—	—	100,000
2023-11-11	PRMEPrime Medicine, Inc.G Gift	Director, See Remarks	GGift	−7,500 sh	—	—	2,560,837
2023-11-11	PRMEPrime Medicine, Inc.G Gift	Director, See Remarks	GGift	−5,000 sh	—	—	27,166
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,748 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−3,196 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.U Disposition from Tender	Director	UDisposition from Tender	−24.7K sh	$19.00	−$470K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−8,111 sh	$19.00	−$154K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,966 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,174 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,036 sh	—	—	0
2023-05-24	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+8,111 sh	—	—	32,830
2023-05-24	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Director	AAward	+12.5K sh	—	—	12,547
2023-03-31	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+498K sh	—	—	497,738
2022-05-25	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+7,737 sh	—	—	24,719
2022-05-25	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Director	AAward	+12.8K sh	—	—	12,790
2021-05-27	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+7,029 sh	—	—	16,982
2021-05-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Director	AAward	+12.1K sh	—	—	12,089
2020-05-28	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Director	AAward	+2,966 sh	—	—	2,966
2020-05-28	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+1,595 sh	—	—	9,953
2020-03-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−3,408 sh	—	—	207,877
2020-03-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+3,408 sh	$6.14	+$20.9K	558,250
2020-02-10	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−6,816 sh	—	—	211,286
2020-02-10	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+6,816 sh	$6.14	+$41.9K	554,283
2020-01-08	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+33.1K sh	$4.59	+$152K	546,914
2020-01-08	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−33.1K sh	—	—	84,208
2019-07-16	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+7,500 sh	$4.59	+$34.4K	513,842
2019-07-16	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−7,500 sh	—	—	117,280
2019-06-20	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+1,570 sh	—	—	8,358
2019-06-20	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Director	AAward	+2,174 sh	—	—	2,174
2019-03-18	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−2,329 sh	$30.27	−$70.5K	506,342
2019-03-15	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−7,961 sh	$30.04	−$239K	508,671
2019-03-14	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−1,506 sh	$30.05	−$45.3K	516,632
2019-03-13	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−7,782 sh	$30.06	−$234K	518,138
2019-02-27	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−1,814 sh	$30.01	−$54.4K	525,617
2019-02-26	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−635 sh	$30.13	−$19.1K	527,431
2019-02-19	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−918 sh	$30.05	−$27.6K	528,066
2019-02-15	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−12K sh	$30.02	−$360K	528,984
2019-02-13	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, CEO & President	SSale	−3,934 sh	$30.00	−$118K	540,986

Recent filings

Accepted (ET)
Jun 304
Gottesdiener Keith Michael0001193125-26-291052
SEC(opens sec.gov)
Sep 294
Gottesdiener Keith Michael0001193125-25-223384
SEC(opens sec.gov)
May 124
Gottesdiener Keith Michael0001894562-25-000019
SEC(opens sec.gov)
Mar 44
Gottesdiener Keith Michael0001894562-25-000014
SEC(opens sec.gov)
Dec 94
Gottesdiener Keith Michael0001894562-24-000049
SEC(opens sec.gov)
Oct 104
Gottesdiener Keith Michael0001894562-24-000043
SEC(opens sec.gov)
Jun 74
Gottesdiener Keith Michael0001894562-24-000026
SEC(opens sec.gov)
Feb 274
Gottesdiener Keith Michael0001894562-24-000016
SEC(opens sec.gov)
Nov 144
Gottesdiener Keith Michael0001894562-23-000034
SEC(opens sec.gov)
Nov 134
Gottesdiener Keith Michael0001104659-23-117102
SEC(opens sec.gov)

Companies

Address

C/O SEPTERNA, INC. 250 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080